Literature DB >> 19601534

[A case of mesalazine-induced lung injury improved by only discontinuation of mesalazine].

Takashi Shimizu1, Masachika Hayashi, Natsue Shimizu, Shin-ichi Kinebuchi, Jozi Toyama.   

Abstract

We reported a case of drug-induced lung injury associated with mesalazine. A 50-year-old woman was diagnosed as having ulcerative colitis and treated with mesalazine. After administration for 1 month, the patient developed dry cough, fever and bilateral pulmonary infiltrates. A bronchoalveolar lavage showed 6.5 x 10(5) cells/ml, with 58% lymphocytes and 20% eosinophils. Improvement in clinical symptoms and radiological abnormalities occurred spontaneously after discontinuation of mesalazine. Even though the signs and symptoms of mesalazine-induced lung injury are similar to those of the pulmonary involvement of inflammatory bowel disease, it is important to distinguish them differences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601534

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  4 in total

1.  Mesalamine-induced refractory fever and progressive increase in creatinine level and leukocyte count in a patient with enteropathic arthritis.

Authors:  Metin Işık
Journal:  Eur J Rheumatol       Date:  2014-09-01

2.  Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.

Authors:  José Ferrusquía; Isabel Pérez-Martínez; Ricardo Gómez de la Torre; María Luisa Fernández-Almira; Ruth de Francisco; Luis Rodrigo; Sabino Riestra
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

3.  Mesalazine-induced eosinophilic pneumonia with bone marrow infiltration: a case report and literature review.

Authors:  Yunjian Zhang; Ling Luo; Xiaofang Wang; Xiaoyang Liu; Xiaoyan Wang; Yi Ding
Journal:  Ther Clin Risk Manag       Date:  2016-06-14       Impact factor: 2.423

4.  Mesalazine-induced lung injury with severe respiratory failure successfully treated with steroids and non-invasive positive pressure ventilation.

Authors:  Hajime Oi; Atsushi Suzuki; Yasuhiko Yamano; Toshiki Yokoyama; Toshiaki Matsuda; Kensuke Kataoka; Yasuhiko Suzuki; Tomoki Kimura; Yasuhiro Kondoh
Journal:  Respir Med Case Rep       Date:  2020-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.